Actively Recruiting
Analysis of RATS, VATS and Open Lung Resections After Neoadjuvant Chemo-immunotherapy in Patients Performed in Five Referred Centers
Led by Scientific Institute San Raffaele · Updated on 2024-11-29
140
Participants Needed
6
Research Sites
54 weeks
Total Duration
On this page
Sponsors
S
Scientific Institute San Raffaele
Lead Sponsor
M
Memorial Sloan Kettering Cancer Center
Collaborating Sponsor
AI-Summary
What this Trial Is About
The study is a retrospective observational study. The study is designed to be multicentric and international and it will analyze medical records from selected patients diagnosed with locally advanced and resectable NSCLC who underwent lung resection by robotic, VATS and open approach after receiving neoadjuvant chemo-immunotherapy. There are no risks for the patients, as this is a retrospective data collection.
CONDITIONS
Official Title
Analysis of RATS, VATS and Open Lung Resections After Neoadjuvant Chemo-immunotherapy in Patients Performed in Five Referred Centers
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Diagnosed with clinical or pathological stage IIB (T1-2, hilar N1, M0) or stage III (any T, N1-2, M0) NSCLC
- Surgically treated with robotic, VATS, or open lung resection with radical intent from January 1, 2016 to March 31, 2024
- Received neoadjuvant chemo-immunotherapy or immunotherapy alone
- Age 18 years or older at the time of surgery
You will not qualify if you...
- Under 18 years old at the time of surgery
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 6 locations
1
Baptist Health South Florida
Miami, Florida, United States, 33176
Actively Recruiting
2
Memorial Sloan Kettering Cancer Center
New York, New York, United States, 10065
Actively Recruiting
3
West Virginia University
Morgantown, West Virginia, United States, 26506
Actively Recruiting
4
Istituto Clinico Humanitas
Rozzano, Milan, Italy, 20089
Actively Recruiting
5
Scientific Institute Ospedale San Raffaele
Milan, Italy, 20132
Actively Recruiting
6
Regina Elena National Cancer Institute
Rome, Italy, 00144
Actively Recruiting
Research Team
P
Pierluigi Novellis, Medical Doctor
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here